| Literature DB >> 33053734 |
Itzen Aguiñiga-Sánchez1,2, Marcos Soto-Hernández2,3, Jorge Cadena-Iñiguez2,4, Mario Suwalsky5, José R Colina6, Ivan Castillo7, Juana Rosado-Pérez8, Víctor M Mendoza-Núñez8, Edelmiro Santiago-Osorio1,2.
Abstract
In addition to their own antioxidants, human cells feed on external antioxidants, such as the phenolic compounds of fruits and vegetables, which work together to keep oxidative stress in check. Sechium edule, an edible species of chayote, has phenolic compounds with antioxidant activity and antineoplastic activity. A Sechium hybrid shows one thousand times greater antineoplastic activity than edible species, but its antioxidant and anti-inflammatory activities and the content of phenolic compounds are unknown. The aim of this study was to determine the antioxidant and anti-inflammatory capacity of the extract of fruits of the Sechium hybrid in vitro and in vivo. Phytochemical analysis using HPLC showed that the extract of the Sechium hybrid has at least 16 phenolic compounds; galangin, naringenin, phloretin and chlorogenic acid are the most abundant. In an in vitro assay, this extract inhibited 2,2-diphenyl-L-picrylhydrazyl (DPPH) activity and protected the dimyristoylphosphatidylethanolamine (DMPE) phospholipid model cell membrane from oxidation mediated by hypochlorous acid (HClO). In vivo, it was identified that the most abundant metabolites in the extract enter the bloodstream of the treated mice. On the other hand, the extract reduces the levels of tumor necrosis factor alpha (TNFα), interferon gamma (IFNγ), and interleukin-6 (IL-6) but increases interleukin-10 (IL-10) and glutathione peroxidase levels. Our findings indicate that intake of the fruits of the Sechium hybrid leads to antioxidant and anti-inflammatory effects in a mouse model. Therefore, these results support the possibility of exploring the clinical effect of this hybrid in humans.Entities:
Keywords: IL-10; TNFα; chayote; glutathione peroxidase; phenolic compounds
Mesh:
Substances:
Year: 2020 PMID: 33053734 PMCID: PMC7587193 DOI: 10.3390/molecules25204637
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Identification of compounds present in the H387 07 hybrid fruit extract by HPLC. (A) Chromatograms of the flavonoids at 254 nm; (B) presence of apigenin at 316 nm and unidentified compounds; and (C) phenolic acids at 280 nm.
Concentration of flavonoids and phenolic acids in the extract of fruits of hybrid H387 07 obtained from HPLC.
| H387 07 Hybrid Extract | |||
|---|---|---|---|
| Flavonoids | Phenolic Acids | ||
| (mg/g of Extract) | |||
| Rutin | 1.273 | Gallic acid | 0.056 |
| Phlorizin | 0.0168 | Chlorogenic acid | 4.224 |
| Myricetin | 0.889 | Syringic acid | 0.016 |
| Quercetin | 0.005 | Vanillic acid | 0.087 |
| Naringenin | 3.304 | 0.084 | |
| Phloretin | 4.616 | Caffeic acid | 0.187 |
| Galangin | 21.940 | Ferulic acid | 0.064 |
| Apigenin | 0.362 | 0.029 | |
Figure 2Chemical structure of flavonoids and phenolic acids identified in the extract of fruits of hybrid H387 07.
Figure 3Inhibition of 2,2-diphenyl-L-picrylhydrazyl (DPPH) activity by extract H387 07. The average of three independent experiments ± standard deviation, * Significant difference (Tukey p < 0.05).
Figure 4X-ray diffraction patterns of (A) dimyristoylphosphatidylcholine (DMPC) and (B) dimyristoylphosphatidylethanolamine (DMPE) bilayers immersed in water and hypochlorous acid (HClO); (C) DMPE in water in the presence of or absence of HClO 10 ng/mL, and with increasing concentrations of the extract of H387 07 hybrid; small-angle (SA) and wide-angle (WA) reflections.
Figure 5Concentration of secondary metabolites present in serum from mice treated with the extract of the Sechium H387 07 hybrid. (A) Galangin, (B) phloretin, (C) naringenin, and (D) chlorogenic acid.
Concentrations of serum inflammatory cytokines from mice treated intraperitoneally with 8, 250, 500 and 1000 mg/kg extract of the Sechium H387 07 hybrid.
| Cytokine (pg/mL) | Without | H387 07 Hybrid Extract (mg/kg) | ||||
|---|---|---|---|---|---|---|
| 0 | 8 | 250 | 500 | 1000 | ||
| TNFα | 255.7 ± 37 | 257.9 ± 26 | 144.8 ± 42 * | 200.4 ± 9 * | 143.1 ± 23 * | 92.46 ± 25 * |
| INFγ | 69.7 ± 6 | 56.6 ± 3 | 49.6 ± 7 | 27.5 ± 8 * | 19.07 ± 6 * | 26.9 ± 3 * |
| IL-6 | 590.0 ± 56 | 512.5 ± 60 | 125.8 ± 47 * | 378.7 ± 20 * | 231 ± 41 * | 237 ± 27 * |
| IL-10 | 342.6 ± 75 | 276.9 ± 82 | 1070 ± 375 * | 2831 ± 168 * | 3870 ± 480 * | 4156 ± 200 * |
n = 10 mice per treatment ± standard deviation, * ANOVA, significant difference (Tukey p < 0.05).
Figure 6Concentration of glutathione peroxidase glutathione peroxidase (GPx) in blood lysates of mice treated or not treated with the H387 07 extract for a month with or without induction of oxidation by carbon tetrachloride (CCl4). n = 10 mice per treatment ± standard deviation. * Significant difference (Tukey p < 0.05).